{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:02:00Z","timestamp":1790107320124,"version":"4.0.1"},"reference-count":57,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>AI is increasingly being integrated into diabetes care, with growing evidence supporting its potential to improve clinical decision-making, risk prediction, and self-management. However, the lived experiences, expectations, and concerns of those involved in its implementation have not been adequately synthesized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to synthesize qualitative evidence on the perspectives of patients, caregivers, health care professionals (HCPs), and other stakeholders regarding the integration of AI in diabetes management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched MEDLINE via PubMed, Web of Science, Scopus, CINAHL, and PsycINFO from inception to February 17, 2026. Eligible studies examined the perspectives of adult patients, caregivers, health care professionals, or administrators on AI-enabled tools for diabetes management, self-management, clinical decision support, or the prevention of complications, and used qualitative methods or reported a separately analyzable qualitative component. Tools required an identifiable data-driven function for prediction, classification, recommendation, personalization, or decision support. Studies focused exclusively on image-based diagnosis, technical validation, or digital tools without an identifiable AI component were excluded. Two reviewers (HM-M and JM-A) independently screened studies and extracted data. Methodological limitations were assessed using the Joanna Briggs Institute (JBI) checklist and the Cochrane Qualitative Methodological Limitations Tool (CAMELOT). Findings were synthesized using thematic synthesis. Confidence was assessed using GRADE-CERQual. A sensitivity analysis excluded questionnaire-based qualitative evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen studies published between 2023 and 2025 were included, representing at least 738 participants across 9 countries. Participants included individuals with type 1 or type 2 diabetes, family caregivers, doctors, nurses, specialists, administrators, and other health care staff. Studies evaluated large language models, AI-enabled mobile applications and wearables, glucose-prediction systems, and clinical decision-support tools. Exposure ranged from direct use of functioning systems to evaluation of prototypes, wireframes, and hypothetical applications. Four analytical themes and 13 subthemes were identified. Stakeholders perceived that AI could support preventive and individualized care, education, self-management, and decision-making. Concerns included accuracy, bias, privacy, accountability, increased workload, caregiver burden, loss of professional autonomy, and erosion of human-centered care. Participants emphasized explainability, intuitive design, integration with existing systems, tailored training, and continued access to human support. Eleven findings were rated as high confidence and 2 as moderate confidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although stakeholders perceived AI to be useful for diabetes care, these qualitative findings do not demonstrate clinical effectiveness, safety, or improved patient outcomes. Evidence was limited by heterogeneity in AI modalities, stakeholder groups, diabetes contexts, and technology exposure, as well as demographic imbalance, restricted reporting of researcher reflexivity, and reliance on prototype or hypothetical systems. Implementation should prioritize transparent design, clinical validation, data governance, human oversight, and tailored support, while preserving professional judgment and person-centered relationships.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/105329","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:11:15Z","timestamp":1790104275000},"page":"e105329-e105329","source":"Crossref","is-referenced-by-count":0,"title":["Stakeholder Perspectives on the Integration of AI in Diabetes Care: Systematic Review of Qualitative Studies"],"prefix":"10.2196","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3991-3593","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Mart\u00ednez-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8241-0537","authenticated-orcid":false,"given":"Julia","family":"Mart\u00ednez-Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1713-4007","authenticated-orcid":false,"given":"Bel\u00e9n","family":"S\u00e1nchez-Rojo-Huertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0364-8032","authenticated-orcid":false,"given":"Mar\u00eda Eugenia","family":"Visier-Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4127-0483","authenticated-orcid":false,"given":"Fernando","family":"Sebasti\u00e1n-Valles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7673-986X","authenticated-orcid":false,"given":"Ana","family":"D\u00edez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3594-7183","authenticated-orcid":false,"given":"Ana","family":"P\u00e9rez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6121-7893","authenticated-orcid":false,"given":"Vicente","family":"Mart\u00ednez-Vizca\u00edno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"1","key":"R1","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-023-04698-z","article-title":"Revolutionizing healthcare: the role of artificial intelligence in clinical practice","volume":"23","author":"Alowais","journal-title":"BMC Med Educ"},{"issue":"2","key":"R2","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.7861\/fhj.2021-0095","article-title":"Artificial intelligence in healthcare: transforming the practice of medicine","volume":"8","author":"Bajwa","journal-title":"Future Healthc J"},{"issue":"8","key":"R3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","article-title":"Artificial intelligence in radiology","volume":"18","author":"Hosny","journal-title":"Nat Rev Cancer"},{"issue":"7639","key":"R4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21056","article-title":"Dermatologist-level classification of skin cancer with deep neural networks","volume":"542","author":"Esteva","journal-title":"Nature"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02658-5","article-title":"Precision medicine in the era of artificial intelligence: implications in chronic disease management","volume":"18","author":"Subramanian","journal-title":"J Transl Med"},{"issue":"12","key":"R6","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-021-01423-2","article-title":"Artificial intelligence in current diabetes management and prediction","volume":"21","author":"Nomura","journal-title":"Curr Diab Rep"},{"issue":"10","key":"R7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.aprim.2017.06.012","article-title":"Dietary program and physical activity impact on biochemical markers in patients with type 2 diabetes: a systematic review","volume":"50","author":"Barreira","journal-title":"Aten Primaria"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2024.105783","article-title":"Developing an AI-Based clinical decision support system for basal insulin titration in type 2 diabetes in primary Care: a mixed-methods evaluation using heuristic analysis, user feedback, and eye tracking","volume":"195","author":"Thomsen","journal-title":"Int J Med Inform"},{"issue":"8","key":"R9","doi-asserted-by":"publisher","DOI":"10.1530\/EC-23-0132","article-title":"The changing landscape of automated insulin delivery in the management of type 1 diabetes","volume":"12","author":"Lakshman","journal-title":"Endocr Connect"},{"issue":"10","key":"R10","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1007\/s00125-024-06165-w","article-title":"The role of automated insulin delivery technology in diabetes","volume":"67","author":"Boughton","journal-title":"Diabetologia"},{"issue":"5","key":"R11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s13300-023-01394-5","article-title":"A systematic review of commercial hybrid closed-loop automated insulin delivery systems","volume":"14","author":"Peacock","journal-title":"Diabetes Ther"},{"issue":"2","key":"R12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1932296817710475","article-title":"Artificial intelligence methodologies and their application to diabetes","volume":"12","author":"Rigla","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"R13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/10547738211067880","article-title":"Perceptions of treatment burden among caregivers of elders with diabetes and co-morbid Alzheimer\u2019s disease and related dementias: a qualitative study","volume":"32","author":"Vaughan Dickson","journal-title":"Clin Nurs Res"},{"issue":"2","key":"R14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/dme.12823","article-title":"The artificial pancreas: evaluating risk of hypoglycaemia following errors that can be expected with prolonged at-home use","volume":"33","author":"Wolpert","journal-title":"Diabet Med"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabet.2018.04.003","article-title":"A critical review and analysis of ethical issues associated with the artificial pancreas","volume":"45","author":"Quintal","journal-title":"Diabetes Metab"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/19322968211043498","article-title":"Six digital health technologies that will transform diabetes","volume":"17","author":"Klonoff","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"R17","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2337\/dc22-1929","article-title":"An integrated digital health care platform for diabetes management with AI-based dietary management: 48-week results from a randomized controlled trial","volume":"46","author":"Lee","journal-title":"Diabetes Care"},{"issue":"5","key":"R18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.8910","article-title":"Real-time AI-assisted insulin titration system for glucose control in patients with type 2 diabetes: a randomized clinical trial","volume":"8","author":"Ying","journal-title":"JAMA Netw Open"},{"issue":"8","key":"R19","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61081403","article-title":"Barriers and facilitators to artificial intelligence implementation in diabetes management from healthcare workers\u2019 perspective: a scoping review","volume":"61","author":"Cangelosi","journal-title":"Medicina (Kaunas)"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Higgins J Thomas J Chandler J et al. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. John Wiley & Sons, Incorporated; 2019. [doi: 10.1002\/9781119536604]","DOI":"10.1002\/9781119536604"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-181","article-title":"Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ","volume":"12","author":"Tong","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"R22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1177\/1049732312452938","article-title":"Beyond PICO: the SPIDER tool for qualitative evidence synthesis","volume":"22","author":"Cooke","journal-title":"Qual Health Res"},{"issue":"1","key":"R23","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","journal-title":"Syst Rev"},{"issue":"3","key":"R24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/XEB.0000000000000062","article-title":"Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation","volume":"13","author":"Lockwood","journal-title":"Int J Evid Based Healthc"},{"issue":"6","key":"R25","doi-asserted-by":"publisher","DOI":"10.1002\/cesm.12058","article-title":"Developing CAMELOT for assessing methodological limitations of qualitative research for inclusion in qualitative evidence syntheses","volume":"2","author":"Munthe-Kaas","journal-title":"Cochrane Evid Synth Methods"},{"issue":"S1","key":"R26","doi-asserted-by":"publisher","first-page":"s13012","DOI":"10.1186\/s13012-017-0688-3","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series","volume":"13","author":"Lewin","journal-title":"Implementation Sci"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251322654","article-title":"Acceptability of an AI-enabled family module in a mobile app for enhanced diabetes management: patient and family perspectives","volume":"11","author":"Yoon","journal-title":"Digit HEALTH"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.2196\/45032","article-title":"An assessment of how clinicians and staff members use a diabetes artificial intelligence prediction tool: mixed methods study","volume":"2","author":"Liaw","journal-title":"JMIR AI"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1177\/11795514241235514","article-title":"Benefit-risk assessment of chatGPT applications in the field of diabetes and metabolic illnesses: a qualitative study","volume":"17","author":"Jairoun","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"4","key":"R30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.81855","article-title":"Impact of ChatGPT on diabetes mellitus self-management among patients in Saudi Arabia","volume":"17","author":"Alanzi","journal-title":"Cureus"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.2196\/48310","article-title":"Acceptability of mobile app\u2013based motivational interviewing and preferences for app features to support self-management in patients with type 2 diabetes: qualitative study","volume":"9","author":"Yoon","journal-title":"JMIR Diabetes"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.2196\/46487","article-title":"Artificial intelligence in health care-understanding patient information needs and designing comprehensible transparency: qualitative study","volume":"2","author":"Robinson","journal-title":"JMIR AI"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251329991","article-title":"Healthcare professionals\u2019 perspectives on artificial intelligence (AI)-based mobile applications (apps) for diabetes education and behavioural management","volume":"11","author":"Lim","journal-title":"Digit HEALTH"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.2196\/50939","article-title":"Assessing the utility, impact, and adoption challenges of an artificial intelligence-enabled prescription advisory tool for type 2 diabetes management: qualitative study","volume":"11","author":"Yoon","journal-title":"JMIR Hum Factors"},{"issue":"1","key":"R35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/shb.shb_92_24","article-title":"Patient perceptions toward the application of artificial intelligence in diabetes care: a qualitative study","volume":"8","author":"Krisnan","journal-title":"Asian J Soc Health Behav"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Samimi R Bhattacharya A Gosak L Stiglic G Verbert K . Visual-conversational interface for evidence-based explanation of diabetes risk prediction. In: CUI \u201925: Proceedings of the 7th ACM Conference on Conversational User Interfaces. Association for Computing Machinery; 2025. [doi: 10.1145\/3719160.3736616]","DOI":"10.1145\/3719160.3736616"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.2196\/38474","article-title":"Integration of the vision of people with diabetes Into the development process to improve self-management via diabetes apps: qualitative interview study","volume":"8","author":"Klemme","journal-title":"JMIR Diabetes"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijhcs.2023.103003","article-title":"Co-designing opportunities for human-centred machine learning in supporting type 1 diabetes decision-making","volume":"173","author":"Stawarz","journal-title":"Int J Hum Comput Stud"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1563003","article-title":"Perspectives of people with diabetes on AI-integrated wearable devices: perceived benefits, barriers, and opportunities for self-management","volume":"12","author":"Alzghaibi","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"R40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1108\/IJPHM-10-2024-0111","article-title":"Adoption of AI-based diabetes diagnosis: a patient and institutional perspective in Maharashtra and Karnataka","volume":"20","author":"Roy","journal-title":"Int J Pharm Healthc Mark"},{"issue":"1","key":"R41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","journal-title":"BMC Med Res Methodol"},{"issue":"S1","key":"R42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13012-017-0689-2","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2014paper 2: how to make an overall CERQual assessment of confidence and create a summary of qualitative findings table","volume":"13","author":"Lewin","journal-title":"Implementation Sci"},{"issue":"S1","key":"R43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13012-017-0690-9","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2014paper 3: how to assess methodological limitations","volume":"13","author":"Munthe-Kaas","journal-title":"Implementation Sci"},{"issue":"S1","key":"R44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13012-017-0691-8","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2014paper 4: how to assess coherence","volume":"13","author":"Colvin","journal-title":"Implementation Sci"},{"issue":"S1","key":"R45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13012-017-0692-7","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2014paper 5: how to assess adequacy of data","volume":"13","author":"Glenton","journal-title":"Implementation Sci"},{"issue":"S1","key":"R46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13012-017-0693-6","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2013paper 6: how to assess relevance of the data","volume":"13","author":"Noyes","journal-title":"Implementation Sci"},{"issue":"1","key":"R47","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/heq.2018.0037","article-title":"The application of medical artificial intelligence technology in rural areas of developing countries","volume":"2","author":"Guo","journal-title":"Health Equity"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2020-106820","article-title":"Who is afraid of black box algorithms? On the epistemological and ethical basis of trust in medical AI","author":"Dur\u00e1n","journal-title":"J Med Ethics"},{"issue":"4","key":"R49","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83132","article-title":"Artificial intelligence tools that improve medication adherence in patients with chronic noncommunicable diseases: an updated review","volume":"17","author":"Zavaleta-Monestel","journal-title":"Cureus"},{"issue":"3","key":"R50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijnss.2025.04.013","article-title":"Healthcare providers\u2019 perceptions of artificial intelligence in diabetes care: a cross-sectional study in China","volume":"12","author":"Mo","journal-title":"Int J Nurs Sci"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.2196\/83030","article-title":"Patient perceptions of artificial intelligence in diabetes self-management: cross-sectional survey study","volume":"10","author":"Martini","journal-title":"JMIR Form Res"},{"issue":"5","key":"R52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.scib.2024.01.004","article-title":"Large language models for diabetes care: potentials and prospects","volume":"69","author":"Sheng","journal-title":"Sci Bull (Beijing)"},{"issue":"11","key":"R53","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.1109\/TFUZZ.2024.3443878","article-title":"Multicenter knowledge transfer calibration with rapid zeroth-order TSK fuzzy system for small sample epileptic EEG signals","volume":"32","author":"Wang","journal-title":"IEEE Trans Fuzzy Syst"},{"issue":"4","key":"R54","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1109\/TFUZZ.2026.3658901","article-title":"Knowledge calibration fusion and label space graph regularization-based multicenter fuzzy systems","volume":"34","author":"Wang","journal-title":"IEEE Trans Fuzzy Syst"},{"key":"R55","unstructured":"Ethics and Governance of Artificial Intelligence for Health: WHO Guidance. World Health Organization; 2021. URL: https:\/\/iris.who.int\/bitstream\/handle\/10665\/341996\/9789240029200-eng.pdf?sequence=1 [Accessed 05-09-2026] ISBN: 978-92-4-002920-0"},{"key":"#cr-split#-R56.1","unstructured":"Regulation (EU) 2024\/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence and amending Regulations (EC) No 300\/2008, (EU) No 167\/2013, (EU) No 168\/2013, (EU) 2018\/858, (EU) 2018\/1139 and (EU) 2019\/2144 and Directives 2014\/90\/EU, (EU) 2016\/797 and (EU) 2020\/1828 (Artificial Intelligence Act). European Union"},{"key":"#cr-split#-R56.2","unstructured":"Jul 12, 2024. URL: https:\/\/eur-lex.europa.eu\/eli\/reg\/2024\/1689\/oj [Accessed 05-09-2026]"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:11:18Z","timestamp":1790104278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2026\/1\/e105329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":57,"URL":"https:\/\/doi.org\/10.2196\/105329","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"v28i1e105329"}}